Bio

Christopher Harris is a principal at Advantage Capital. As a member of the firm’s investment group, he is responsible for sourcing, due diligence and valuation analysis of current and prospective investments. He serves on the board of directors for several portfolio companies, including GENICON, Prioria Robotics, Beehive Industries, RepEquity, SOMS Technologies and Quoddy. Christopher also manages Advantage's investments in Veran Medical Technologies, Minimally Invasive Devices and OrderWithMe. Prior to joining Advantage Capital, Christopher worked for GE Capital as an assistant vice president, where he helped establish the company’s presence in large cap leveraged finance underwriting and investing. He joined GE in the FMP program and cycled throughout various operating and finance roles before joining on with the large cap leverage finance team. Christopher received his MBA from the Tuck School of Business at Dartmouth and a bachelor’s degree in economics from Trinity College in Hartford, Connecticut.